Neuland Laboratories Limited.

BSE: NEULANDLAB524558ISIN INE794A01010

Healthcare
Pharmaceuticals
BSE 500

BSE listing

Share price

₹22,875.70+219.50 (+0.97%)

as of 18 Sep 2026

52W high: ₹24,235.05
52W low: ₹11,500.00
Off 52W high: -5.61%
1M return: -1.81%
3M return: +31.85%
6M return: +90.56%
1Y return: +43.94%
20D avg volume: 2,120
50 DMA: ₹21,525.90
200 DMA: ₹16,736.21

Key ratios Consolidated

Market cap: ₹29,349 Cr
Current price: ₹22,875.70
52W high / low: ₹24,235.05 / ₹11,500.00
Face value: ₹10.00
P/E: 58.96
P/B: —
EPS (TTM): ₹387.98
Book value / share: —
ROE: —
ROCE: 23.10%
Operating margin: —
Net margin: —
Debt / equity: 0.10
Net debt: ₹119.95 Cr
Interest cover: 21.42
Dividend yield: 0.15%
Dividend / share (TTM): ₹34.00
Payout: 8.76%
Cash conversion cycle: 141.2 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	641.58	776.25	439.71	514.27	292.75	328.36	398.03	310.84	439.60	385.01	392.83	417.75
	8.49	12.46	8.05	1.80	7.86	7.46	3.91	4.33	4.81	5.36	2.10	3.05
	452.22	501.21	393.29	386.64	283.04	296.52	329.95	265.75	335.19	298.17	290.45	299.20
	228.77	230.79	199.86	227.64	161.48	141.24	145.44	133.17	154.95	174.98	153.45	139.13
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—	—
	106.43	98.47	88.83	80.37	73.47	66.46	69.34	63.07	73.14	62.49	65.73	68.96
	6.97	7.21	6.79	5.37	4.58	2.35	2.22	1.06	2.67	3.61	3.74	4.43
	26.56	25.09	23.92	22.54	20.19	16.89	16.30	16.07	16.28	16.46	15.14	14.51
	91.23	101.16	84.69	94.75	71.25	83.93	36.37	25.79	30.07	35.58	27.25	19.72
	197.85	287.50	54.48	129.44	17.57	39.30	71.99	49.42	109.22	92.20	104.48	121.59
	0.00	0.00	0.00	0.00	0.00	0.00	55.78	0.00	20.63	0.00	0.00	0.00
	197.85	287.50	54.48	129.44	17.57	39.30	127.77	49.42	129.84	92.20	104.48	121.59
	50.17	74.82	13.90	32.58	3.67	11.49	26.18	16.58	31.97	24.64	23.09	32.35
	147.67	212.67	40.57	96.85	13.90	27.81	101.59	32.84	97.87	67.56	81.39	89.25
	115.10	165.76	31.62	75.49	10.83	21.67	79.18	25.60	76.28	52.66	63.44	69.56
Key metrics
	231.38	319.80	85.19	157.35	42.34	58.54	146.29	66.55	148.79	112.27	123.36	140.53
	36.10%	41.20%	19.40%	30.60%	14.50%	17.80%	36.80%	21.40%	33.80%	29.20%	31.40%	33.60%
	23.00%	27.40%	9.20%	18.80%	4.70%	8.50%	25.50%	10.60%	22.30%	17.50%	20.70%	21.40%
	—	13.30%	—	7.10%	—	2.40%	—	—	—	—	—	—
	119.20%	136.40%	10.50%	65.40%	-33.40%	-14.70%	1.30%	-25.60%	—	—	—	—
	962.40%	664.70%	-60.10%	194.90%	-85.80%	-58.80%	24.80%	-63.20%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18
Income statement
	2,372	2,023	1,477	1,559	1,191	951.08	936.91	762.71	666.83	529.16
	30.80	30.17	20.51	12.54	9.75	2.08	16.09	3.89	3.49	4.54
	1,733	1,564	1,227	1,170	985.20	870.99	847.67	713.67	649.98	519.76
	887.06	819.76	574.81	632.43	487.74	437.55	439.66	391.36	360.44	281.09
	0.00	0.00	0.00	—	—	—	—	—	—	—
	374.10	341.14	272.00	257.06	201.79	182.47	149.74	123.56	110.46	—
	26.34	23.95	8.30	14.00	13.07	13.49	17.90	21.57	15.66	18.93
	98.11	91.74	65.55	59.70	52.78	49.04	39.68	31.28	25.86	—
	371.83	351.84	293.94	105.13	103.78	—	81.66	59.47	54.85	54.13
	669.27	488.98	269.93	401.44	215.75	82.16	105.33	52.92	20.34	13.93
	0.00	0.00	76.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	669.27	488.98	346.33	401.44	215.75	82.16	105.33	52.92	20.34	13.93
	171.47	124.98	86.22	101.36	52.23	18.34	24.70	36.71	3.90	1.87
	497.76	364.00	260.11	300.08	163.52	63.82	80.63	16.21	16.44	12.06
	387.97	283.71	202.74	233.89	127.45	49.74	62.85	12.63	13.06	—
Key metrics
	793.72	604.67	420.18	475.14	281.60	144.69	162.91	105.77	61.86	32.86
	33.46%	29.90%	28.50%	30.50%	23.60%	15.20%	17.40%	13.90%	9.30%	6.20%
	20.99%	18.00%	17.60%	19.30%	13.70%	6.70%	8.60%	2.10%	2.50%	2.30%
	—	23.10%	20.70%	—	—	—	—	—	—	—
	—	37.00%	-5.20%	30.80%	25.20%	1.50%	22.80%	14.40%	26.00%	—
	—	39.90%	-13.30%	83.50%	156.20%	-20.80%	397.40%	-1.40%	36.30%	—
	—	-43.49	110.92	—	—	—	—	—	—	—
	—	0.95	1.22	—	—	—	—	—	—	—
	—	0.10	0.09	—	—	—	—	—	—	—
	—	119.95	4.08	—	—	—	—	—	—	—
	—	141.2	111.0	—	—	—	—	—	—	—
Balance sheet
	—	2,930	2,180	—	—	—	—	—	—	—
	—	1,483	1,140	—	—	—	—	—	—	—
	—	76.67	131.93	—	—	—	—	—	—	—
	—	541.35	315.72	—	—	—	—	—	—	—
	—	510.29	385.76	—	—	—	—	—	—	—
	—	72.19	69.30	—	—	—	—	—	—	—
	—	892.29	673.71	—	—	—	—	—	—	—
	—	269.14	252.20	—	—	—	—	—	—	—
	—	710.20	465.69	—	—	—	—	—	—	—
	—	196.62	136.01	—	—	—	—	—	—	—
	—	35.67	45.28	—	—	—	—	—	—	—
	—	160.95	90.73	—	—	—	—	—	—	—
	—	1,874	1,525	—	—	—	—	—	—	—
Cash flow
	—	346.68	317.38	—	—	—	—	—	—	—
	—	-423.73	-298.16	—	—	—	—	—	—	—
	—	20.98	24.96	—	—	—	—	—	—	—
	—	390.17	206.46	—	—	—	—	—	—	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	641.58	776.25	439.71	514.27	292.75	328.36	398.03	310.84	439.60	385.01	392.83	417.75
	8.49	12.46	8.05	1.80	7.86	7.46	3.91	4.33	4.81	5.36	2.10	3.05
	452.53	501.66	393.49	387.03	283.23	296.84	330.17	266.64	334.73	298.29	291.15	299.39
	228.77	230.79	199.86	227.64	161.48	141.24	145.44	133.17	154.95	174.98	153.45	139.13
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—	—
	103.02	95.27	85.99	76.68	70.88	64.19	67.21	59.03	70.97	61.01	63.34	66.49
	6.97	7.23	6.79	5.34	4.58	2.35	2.22	1.06	2.67	3.61	3.74	4.43
	26.56	25.09	23.92	22.54	20.19	16.89	16.30	16.07	16.28	16.46	15.14	14.51
	94.95	104.79	87.73	98.86	74.03	86.51	38.72	30.72	31.77	37.19	30.34	22.38
	197.54	287.04	54.27	129.04	17.38	38.98	71.77	48.54	109.68	92.08	103.78	121.40
	0.00	0.00	0.00	0.00	0.00	0.00	55.78	—	20.63	—	—	—
	197.54	287.04	54.27	129.04	17.38	38.98	127.55	48.54	130.31	92.08	103.78	121.40
	50.17	74.52	13.86	32.58	3.67	11.25	26.15	16.58	31.97	24.47	23.08	32.34
	147.36	212.52	40.42	96.46	13.71	27.73	101.39	31.96	98.34	67.61	80.70	89.06
	114.86	165.65	31.50	75.18	10.68	21.62	79.03	24.91	76.65	52.70	62.90	69.42
Key metrics
	231.07	319.36	84.98	156.92	42.15	58.22	146.07	65.67	149.26	112.15	122.66	140.34
	36.00%	41.10%	19.30%	30.50%	14.40%	17.70%	36.70%	21.10%	34.00%	29.10%	31.20%	33.60%
	23.00%	27.40%	9.20%	18.80%	4.70%	8.40%	25.50%	10.30%	22.40%	17.60%	20.50%	21.30%
	—	13.30%	—	7.10%	—	2.40%	—	—	—	—	—	—
	119.20%	136.40%	10.50%	65.40%	-33.40%	-14.70%	1.30%	-25.60%	—	—	—	—
	974.80%	666.40%	-60.10%	201.80%	-86.10%	-59.00%	25.60%	-64.10%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18
Income statement
	2,372	2,023	1,477	1,559	1,191	951.08	936.91	762.71	666.83	529.16
	30.80	30.16	20.51	12.54	9.75	2.08	16.09	3.89	3.49	4.54
	1,735	1,565	1,228	1,170	985.73	871.41	848.05	714.10	650.49	520.16
	887.06	819.76	574.81	632.43	487.74	437.55	439.66	391.36	360.44	281.09
	0.00	0.00	0.00	—	—	—	—	—	—	—
	360.96	328.82	261.40	248.53	194.84	175.76	144.02	118.48	104.47	—
	26.33	23.95	8.30	14.00	13.07	13.49	17.90	21.57	15.66	18.92
	98.11	91.73	65.54	59.70	52.78	49.04	39.68	31.28	25.86	22.10
	386.33	365.42	305.50	114.33	111.27	—	87.75	64.98	61.33	61.79
	667.89	487.73	268.97	400.77	215.21	81.74	104.96	52.50	19.84	13.54
	0.00	0.00	76.40	—	—	—	—	—	—	—
	667.89	487.73	345.37	400.77	215.21	81.74	104.96	52.50	19.84	13.54
	171.13	124.63	85.95	101.17	52.09	18.21	24.67	36.62	3.69	1.73
	496.76	363.11	259.43	299.60	163.12	63.53	80.30	15.88	16.14	11.81
	387.19	283.01	202.20	233.51	127.14	49.52	62.58	12.38	12.83	—
Key metrics
	792.33	603.41	419.21	474.47	281.06	144.27	162.54	105.35	61.36	54.56
	33.41%	29.80%	28.40%	30.40%	23.60%	15.20%	17.30%	13.80%	9.20%	10.30%
	20.94%	17.90%	17.60%	19.20%	13.70%	6.70%	8.60%	2.10%	2.40%	2.20%
	—	23.20%	20.70%	—	—	—	—	—	—	—
	—	37.00%	-5.20%	30.80%	25.20%	1.50%	22.80%	14.40%	26.00%	—
	—	40.00%	-13.40%	83.70%	156.80%	-20.90%	405.70%	-1.60%	36.70%	—
	—	-42.59	111.04	—	—	—	—	—	—	—
	—	0.96	1.22	—	—	—	—	—	—	—
	—	0.11	0.09	—	—	—	—	—	—	—
	—	121.31	5.63	—	—	—	—	—	—	—
	—	139.5	108.8	—	—	—	—	—	—	—
Balance sheet
	—	2,928	2,178	—	—	—	—	—	—	—
	—	1,481	1,138	—	—	—	—	—	—	—
	—	75.31	130.38	—	—	—	—	—	—	—
	—	541.35	315.72	—	—	—	—	—	—	—
	—	510.29	385.76	—	—	—	—	—	—	—
	—	71.79	69.17	—	—	—	—	—	—	—
	—	892.27	673.69	—	—	—	—	—	—	—
	—	278.66	260.90	—	—	—	—	—	—	—
	—	719.24	472.84	—	—	—	—	—	—	—
	—	196.62	136.01	—	—	—	—	—	—	—
	—	35.67	45.28	—	—	—	—	—	—	—
	—	160.95	90.73	—	—	—	—	—	—	—
	—	1,866	1,518	—	—	—	—	—	—	—
Cash flow
	—	347.58	317.49	—	—	—	—	—	—	—
	—	-423.74	-298.14	—	—	—	—	—	—	—
	—	20.98	24.96	—	—	—	—	—	—	—
	—	390.17	206.45	—	—	—	—	—	—	—

Compounded growth

Standalone

Sales CAGR 3Y: +19.31%
Sales CAGR 5Y: +16.64%
Sales CAGR 10Y: —
Profit CAGR 3Y: +30.57%
Profit CAGR 5Y: +35.23%
Profit CAGR 10Y: —
Sales YoY (TTM): +78.33%
Profit YoY (TTM): +184.20%

Consolidated

Sales CAGR 3Y: +19.31%
Sales CAGR 5Y: +16.64%
Sales CAGR 10Y: —
Profit CAGR 3Y: +30.57%
Profit CAGR 5Y: +35.18%
Profit CAGR 10Y: —
Sales YoY (TTM): +78.33%
Profit YoY (TTM): +182.59%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding: 32.62%

Holder	Type	Holding	Previous	Change
Davuluri Ownership Trust (Dr. Davuluri Ramamohan Rao, Mr. Davuluri Sucheth Rao and Mr. Davuluri Saharsh Rao - Trustees)	Promoter	25.98%	—	—
MALABAR INDIA FUND LIMITED	Public	5.42%	—	—
MUKUL MAHAVIR AGRAWAL	Public	3.12%	—	—
ICICI PRUDENTIAL BALANCED ADVANTAGE FUND	Public	2.19%	—	—
DAVULURI SUCHETH RAO	Promoter	2.01%	—	—
MAHINDRA MANULIFE ELSS TAX SAVER FUND	Public	1.93%	—	—
SIDDHARTH IYER	Public	1.67%	—	—
RAMAMOHAN RAO DAVULURI	Promoter	1.63%	—	—
HSBC MUTUAL FUND - HSBC SMALL CAP FUND	Public	1.55%	—	—
DAVULURI SAHARSH RAO	Promoter	1.52%	—	—
HDFC MUTUAL FUND - HDFC BSE 500 ETF	Public	1.28%	—	—
BAJAJ FINSERV FLEXI CAP FUND	Public	1.28%	—	—
JUPITER INDIA FUND	Public	1.19%	—	—
KEDIA SECURITIES PRIVATE LIMITED	Public	1.01%	—	—
DAVULURI ROHINI NIVEDITHA RAO	Promoter Group	0.67%	—	—

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

Intimation about Schedule of Analyst / Institutional Investor Meeting on September 23 - 25, 202616 Sep 2026 · Company Update / Analyst / Investor Meet
Press Release15 Sep 2026 · Company Update / Press Release / Media Release
Intimation about Schedule of Analyst / Institutional Investor Meeting on September 15, 2026 and September 17, 20269 Sep 2026 · Company Update / Analyst / Investor Meet
Disclosure under Regulation 30 of SEBI Listing Regulations7 Sep 2026 · Company Update / General
Announcement under Regulation 30 (LODR) - Credit Rating25 Aug 2026 · Company Update / Credit Rating
Copy of Newspaper Publication23 Aug 2026 · Company Update / Newspaper Publication
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Malabar India Fund Ltd17 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Intimation regarding completion of US FDA Inspection14 Aug 2026 · Company Update / General
Transcript of the Earnings Call conducted on August 5, 202610 Aug 2026 · Company Update / Earnings Call Transcript
Intimation about Schedule of Analyst / Institutional Investor Meeting on August 12, 20267 Aug 2026 · Company Update / Analyst / Investor Meet
Copy of Newspaper Publication6 Aug 2026 · Company Update / Newspaper Publication
Audio Recording of the Earnings call conducted on August 5, 20265 Aug 2026 · Company Update / Analyst / Investor Meet
Disclosure under Regulation 30 of SEBI Listing Regulations - Enhancement of manufacturing capacity5 Aug 2026 · Company Update / General
Disclosure under Regulation 30 of SEBI Listing Regulations - Execution of deed of Corporate Guarantee5 Aug 2026 · Company Update / General
Investor Presentation on the Financial Results of the Company for the quarter ended June 30, 20265 Aug 2026 · Company Update / Investor Presentation
Press Release on the Financial Results of the Company for the quarter ended June 30, 20265 Aug 2026 · Company Update / Press Release / Media Release
Unaudited Financial Results of the Company for the quarter ended June 30, 20265 Aug 2026 · Result / Financial Results
Unaudited Financial Results of the Company for the quarter ended June 30, 20265 Aug 2026 · Board Meeting / Outcome of Board Meeting
Voting Results, Scrutinizer Report and proceedings of 42nd Annual General Meeting held on August 4, 20264 Aug 2026 · AGM/EGM / AGM
Voting Results, Scrutinizer Report and proceeding of 42nd Annual General Meeting held on August 4, 20264 Aug 2026 · AGM/EGM / AGM
Intimation under Regulation 30 of SEBI Listing Regulations31 Jul 2026 · Company Update / General
Q1FY27 Earnings Call Intimation28 Jul 2026 · Company Update / Analyst / Investor Meet
Neuland Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 ,inter alia, to consider and approve the unaudited financial ....20 Jul 2026 · Board Meeting / Board Meeting
Intimation of Loss of Share Certificate(s)20 Jul 2026 · Others / Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Announcement under Regulation 30 (LODR) - Credit Rating13 Jul 2026 · Company Update / Credit Rating
Newspaper Publication regarding dispatch of notice of 42nd Annual General Meeting and Integrated Annual Report for FY 2025-2610 Jul 2026 · Company Update / Newspaper Publication
Letter to the Shareholder of the Company in relation to the Notice of 42nd Annual General Meeting and Integrated Annual Report of the Company for FY 2025-269 Jul 2026 · Company Update / General
Business Responsibility and Sustainability Report for FY 2025-269 Jul 2026 · Others / Business Responsibility and Sustainability Reporting (BRSR)
Notice of 42nd Annual General Meeting and Integrated Annual Report FY 20269 Jul 2026 · Others / Reg. 34 (1) Annual Report
Notice of 42nd Annual General Meeting9 Jul 2026 · AGM/EGM / AGM
Certificate under Reg. 74(5) of SEBI (DP) Regulations, 20182 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Closure of Trading Window25 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Copy of Newspaper Publication16 Jun 2026 · Company Update / Newspaper Publication
Intimation about Schedule of Analyst / Institutional Investor Meeting on June 11, 20265 Jun 2026 · Company Update / Analyst / Investor Meet
Intimation about Schedule of Analyst / Institutional Investor Meeting on June 8 & 9, 20263 Jun 2026 · Company Update / Analyst / Investor Meet
Intimation about Schedule of Analyst / Institutional Investor Meeting on June 5, 202631 May 2026 · Company Update / Analyst / Investor Meet
Intimation about Schedule of Analyst / Institutional Investor Meeting on May 28, 202622 May 2026 · Company Update / Analyst / Investor Meet
Transcript of the Earnings Call conducted on May 12, 202616 May 2026 · Company Update / Earnings Call Transcript
Copy of Newspaper Publication15 May 2026 · Company Update / Newspaper Publication
Copy of Newspaper Publication13 May 2026 · Company Update / Newspaper Publication

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 34.0000	24 Jul 2026	24 Jul 2026	—
Final Dividend - Rs. - 12.0000	18 Jul 2025	18 Jul 2025	—
Final Dividend - Rs. - 14.0000	12 Jul 2024	—	—

Board meetings

5 Aug 2026 Board Meeting - Financial Results